Correlation Between Bluejay Diagnostics and Neuroone Medical

Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and Neuroone Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and Neuroone Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bluejay Diagnostics and Neuroone Medical Technologies, you can compare the effects of market volatilities on Bluejay Diagnostics and Neuroone Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of Neuroone Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and Neuroone Medical.

Diversification Opportunities for Bluejay Diagnostics and Neuroone Medical

0.7

Correlation Coefficient

Bluejay Diagnostics  Neuroone Medical

Poor diversification

The 3 months correlation between Bluejay and Neuroone is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and Neuroone Medical Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuroone Medical Tec and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with Neuroone Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuroone Medical Tec has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and Neuroone Medical go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and Neuroone Medical

Given the investment horizon of 90 days Bluejay Diagnostics is expected to under-perform the Neuroone Medical. In addition to that, Bluejay Diagnostics is 1.81 times more volatile than Neuroone Medical Technologies. It trades about -0.08 of its total potential returns per unit of risk. Neuroone Medical Technologies is currently generating about 0.01 per unit of volatility. If you would invest  144.00  in Neuroone Medical Technologies on September 22, 2024 and sell it today you would lose (68.00) from holding Neuroone Medical Technologies or give up 47.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bluejay Diagnostics  vs.  Neuroone Medical Technologies

Bluejay Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly inconsistent fundamental indicators, Bluejay Diagnostics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Neuroone Medical Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuroone Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with Bluejay Diagnostics and Neuroone Medical

The main advantage of trading using opposite Bluejay Diagnostics and Neuroone Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, Neuroone Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuroone Medical will offset losses from the drop in Neuroone Medical's long position.

The idea behind Bluejay Diagnostics and Neuroone Medical Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.